We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Avalo Therapeutics Inc is a clinical-stage precision medicine company that discovers, develops, and commercializes targeted therapeutics for patients with significant unmet clinical needs in immunology, immuno-oncology, and rare genetic diseases. Its pipeline consists of product candidates advancing... Avalo Therapeutics Inc is a clinical-stage precision medicine company that discovers, develops, and commercializes targeted therapeutics for patients with significant unmet clinical needs in immunology, immuno-oncology, and rare genetic diseases. Its pipeline consists of product candidates advancing in development with ongoing clinical programs: AVTX-002, AVTX-007, and AVTX-006. Show more
Topline results from planned Phase 2 trial of AVTX-009 in hidradenitis suppurativa expected in 2026Cash on hand of approximately $110 million as of March 31, 2024 with expected cash runway into...
Appointments include industry veterans Aaron Kantoff, Jonathan Goldman, and Samantha Truex as Independent DirectorsBoard of Director appointments in conjunction with Avaloβs recent acquisition of...
Acquired AVTX-009, Phase-2 ready anti-IL-1Ξ² mAb, in March 2024Increased cash position with private placement financing in March 2024 providing up to $185 million, including initial upfront...
Avalo acquires Phase 2-ready anti-IL-1Ξ² mAb, AVTX-009, through acquisition of AlmataBio, Inc. Topline results from planned Phase 2 trial in hidradenitis suppurativa expected in 2026Executed...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 2.31 | 21.568627451 | 10.71 | 13.23 | 10.26 | 24496 | 11.96054642 | CS |
4 | -3.56 | -21.4716525935 | 16.58 | 17.42 | 8.9174 | 50898 | 12.33688622 | CS |
12 | 8.43 | 183.660130719 | 4.59 | 34.46 | 4.35 | 731006 | 19.31090542 | CS |
26 | -8.7 | -40.0552486188 | 21.72 | 34.46 | 3.9501 | 7151097 | 14.3979214 | CS |
52 | -709.38 | -98.1976744186 | 722.4 | 1130.4 | 3.9501 | 23587662 | 33.15093187 | CS |
156 | -675.78 | -98.1097560976 | 688.8 | 1711.2 | 3.9501 | 8681446 | 39.33010001 | CS |
260 | -675.78 | -98.1097560976 | 688.8 | 1711.2 | 3.9501 | 8681446 | 39.33010001 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions